|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.475 GBX | +10.74% |
|
+10.74% | -36.38% |
| 02:41am | Ixico remains focused on delivering on guidance of 15% revenue growth for full year | RE |
| 02:02am | Earnings Flash (IXI.L) Ixico plc Reports Fiscal H1 Revenue GBP3.9M | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 19.71M | - | ||||
| 41.61B | |||||
| 32.58B | |||||
| 30.69B | - | - | - | - | - |
| 28.84B | |||||
| 25.65B |
- Stock Market
- Equities
- IXI Stock
- Charts IXICO plc
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition